ArticleOPEN ACCESS

Oestrogen (adjunct) versus placebo for women with schizophrenia

Cochrane Database of Systematic Reviews
DOI: 10.1002/14651858.CD012220
0Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the clinical efficacy and safety of oestrogen as an adjunctive treatment versus placebo, in women with schizophrenia or schizophrenia-like illnesses.

Cite

CITATION STYLE

APA

Chua, W. L. L., Grigorov, H. S., & Hiley, J. (2016, June 10). Oestrogen (adjunct) versus placebo for women with schizophrenia. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD012220

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free